The IRE website will be unavailable while we complete routine maintenance on Friday, November 19 from 8-10 am CT.
IRE favicon


Resource ID: #5601
Subject: Health Care
Source: Barron's



Barron's looks at Genentech's new drug for heart-attack victims, TPA; the drug was promoted as the miracle medicine that could dissolve blood clots, but the FDA may have approved it too quickly; finds side effects include fatal reactions such as cerebral hemorrhaging, Jan. 11 and Nov. 21, 1988.

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram